The QualityStocks Daily Wednesday, June 20th, 2018

Today's Top 3 Investment Newsletters

StockMarketWatch (NAKD) +434.59%

PoliticsAndMyPortfolio (ICOTF) +82.32%

QualityStocks (PWCO) +42.57%

The QualityStocks Daily Stock List

Provectus Biopharmaceuticals, Inc. (PVCT)

The Street, TopStockAnalysts, plrinvest, Investors Underground, Real Pennies, PennyStocks24, Club Penny Stocks Network, StreetAuthorityDaily, TheMicrocapNews, Streetwise Reports, AllPennyStocks, Stock News Now, Seeking Alpha, TopPennyStockMovers, StreetInsider, and Wise Alerts reported earlier on Provectus Biopharmaceuticals, Inc. (PVCT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Provectus Biopharmaceuticals, Inc. is a clinical-stage oncology and dermatology Biopharmaceutical Company. It is developing new therapies for the treatment of solid tumor cancers and dermatologic diseases. The Company’s investigational oncology drug is PV-10. PV-10 is an oncolytic immunotherapy enrolling patients in Phase 3 clinical trials for metastatic melanoma. Provectus Biopharmaceuticals is headquartered in Knoxville, Tennessee.

PV-10 is an ablative immunotherapy under investigation in solid tumor cancers. PH-10 is a topical investigational drug for dermatology. It is undergoing clinical testing for psoriasis and atopic dermatitis.

The Company completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis. The intention of PV-10 is to kill only diseased cells upon injection into tumors. Provectus Biopharmaceuticals has received orphan drug designations from the Food and Drug Administration (FDA) for its melanoma and hepatocellular carcinoma indications.

PV-10 is a 10 percent solution of small molecule and halogenated xanthene Rose Bengal. It undergoes administration via direct injection into solid tumor cancers, such as melanoma, liver, and breast. It is not designed to rely on a single pathway, receptor or antigen to work; and there is no known resistance. PH-10 is a topical hydrogel formulation. It yields selective delivery of rose bengal disodium to epithelial tissues.

Regarding PH-10 for psoriasis and atopic dermatitis, a mechanism of action study is underway to measure the clinical and cellular response to PH-10's active investigational agent. A total of 226 subjects have been treated with PH-10 in Phase 1 or Phase 2 Clinical Trials.

Provectus Biopharmaceuticals earlier announced that results from its mechanism of action (MOA) study of PH-10 were presented at the 8th International Congress of Psoriasis: from gene to clinic (Psoriasis G2C), held in London, England from November 30 to December 2, 2017. The MOA work was undertaken by James Krueger, MD, PhD and other members of the Laboratory for Investigative Dermatology at The Rockefeller University.

Mr. Dominic Rodrigues, Chairman of Provectus Pharmaceuticals’ Board of Directors, said, “This study has elucidated PH-10’s novel mechanism of action for psoriasis and, combined with Provectus’ prior clinical work in inflammatory dermatoses, reaffirmed our belief that the Company’s therapeutic platform may now encompass psoriasis and also extend to other skin disorders. The immunologic response outcome that four weeks of topical PH-10 achieved in this study occurs with other topical or systemic drugs approved for psoriasis.”

Today, Provectus Biopharmaceuticals provided an update on its gastrointestinal (GI) cancer clinical development program for its lead investigational drug PV-10, which is administered percutaneously when targeting GI cancer tumors.

The Company’s Phase 1 study of patients with hepatic lesions has treated 18 patients at four U.S. sites to date: six patients with hepatocellular carcinoma (HCC), six patients with metastatic colorectal cancer (mCRC) metastatic to the liver, and six patients with breast cancer, lung cancer, melanoma, ovarian cancer or pancreatic cancer liver metastases.

Results included two of six patients with HCC who remained alive for 58 and 75 months after treatment, the latter with no evidence of disease. Results also included four of five patients with mCRC liver metastases who remained alive 9 to 73 months after treatment. This includes one patient with no evidence of disease at 73 months. Furthermore, results included one patient with pancreatic cancer liver metastases who remained alive 12 months after treatment.

Provectus Biopharmaceuticals, Inc. (PVCT), closed Wednesday's trading session at $0.072, up 2.86%, on 164,878 volume with 17 trades. The average volume for the last 60 days is 321,740 and the stock's 52-week low/high is $0.02/$0.092.


Cocrystal Pharma, Inc. (COCP)

Wall Street Resources, Microcapmillionaires, Promotion Stock Secrets, and PennyStocks Forever reported on Cocrystal Pharma, Inc. (COCP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cocrystal Pharma, Inc. develops novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The Company utilizes innovative technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The design of these technologies, including its nucleoside chemistry expertise and market-centered approach to drug discovery, are to efficiently deliver small molecule therapeutics, which are safe, effective, and convenient to administer. A biotechnology company, Cocrystal Pharma has offices in Tucker, Georgia and Bothell, Washington.

The Company’s proprietary technologies revolve around a structure-based drug discovery strategy teamed up with extensive nucleoside experience. Employing techniques called protein cocrystallization and X-ray crystallography, Cocrystal Pharma quickly identifies novel binding sites, identifies critical inhibitor-protein interactions, and optimizes the structure of the inhibitor in a highly rapid iterative fashion.

Cocrystal Pharma has identified promising, preclinical stage antiviral compounds for unmet medical needs. These include hepatitis, influenza, as well as norovirus infections. The Company is developing a series of compounds that are potent non-nucleoside and nucleoside inhibitors of hepatitis C NS5B RNA dependent RNA polymerase, a replication enzyme vital to viral replication and are highly conserved between all hepatitis C genotypes. Consequently, inhibitors of this enzyme are likely to have multi- or pan-genotypic activity.

Furthermore, Cocrystal Pharma is developing compounds that inhibit hepatitis C helicase and NS5A, two enzymes vital for viral replication. Additionally, the Company has identified a picomolar inhibitor of NS5A, another important viral replication protein. Its compounds that target NS5B hepatitis C polymerase, NS5A, and NS3 helicase will undergo development as a combination treatment.

Cocrystal Pharma previously announced the successful completion and positive data from the Phase 1a/1b study for its lead broad spectrum compound, CC-31244, in healthy volunteers and in hepatitis C virus (HCV)-infected individuals. CC-31244 is a broad-spectrum, potent NS5B non-nucleoside inhibitor (NNI) of HCV replication with a high barrier to resistance. There were no dose-limiting adverse events, study discontinuations because of adverse events, or serious adverse events reported.

Cocrystal Pharma announced in September of 2017 that it entered into a research collaboration with HitGen, Ltd., a private biotechnology company and InterX, Inc., a private computer software company, to develop small molecule drug candidates against several undisclosed targets.

Through the collaboration, Cocrystal Pharma, HitGen, and InterX scientists will apply HitGen's DNA-encoded library (DEL) technology platform and research capabilities in the design, synthesis, and screening of multiple proprietary DELs.

The DEL technology enables a large number of compounds to be quickly identified for specific drug targets. Cocrystal Pharma will utilize its industrialized crystallization and co-crystallization technology to determine at near atomic resolution the structures of HitGen's selected library compounds that interact with drug targets. Also, InterX will utilize its advanced proprietary software to design superior drugs from the information provided by Cocrystal Pharma and HitGen.

Cocrystal Pharma, Inc. (COCP), closed Wednesday's trading session at $4.77, up 7.43%, on 145,625 volume with 494 trades. The average volume for the last 60 days is 118,917 and the stock's 52-week low/high is $1.61/$9.00.


3PEA International, Inc. (TPNL)

HyperSpeedStocks, FeedBlitz, The Next Hot Stock, Volcano Stocks, OtcWizard, and Nebula Stocks reported on 3PEA International, Inc. (TPNL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

3PEA International, Inc. is a vertically integrated provider of unique prepaid card programs and processing services. These are for corporate, consumer, and government applications. By way of its PaySign® brand, the Company designs and develops payment solutions, prepaid card programs, as well as customized payment services. 3PEA International is based in Henderson, Nevada. The Company’s shares trade on the OTC Markets Group’s OTCQB.

3PEA International’s customers include healthcare companies, major pharmaceutical companies, and source plasma providers. In addition, its customers include large multinationals, prestigious universities, and social media companies.

In essence, 3PEA is a payment processor and debit card program manager. It manages programs for many of the world’s largest pharmaceutical manufacturers with co-pay assistance products designed to maximize new patient acquisition, retention, and adherence.

The Company’s customizable prepaid solutions provide substantial cost savings. This is while improving brand recognition and customer loyalty.

3PEA International has its PaySign® brand of prepaid cards. This includes solutions for corporate incentives, payroll, public sector, pharmaceutical co-pay assistance, and source plasma donations, general spend reloadable and other market niches.

Via the PaySign platform, 3PEA International provides a variety of services. This includes transaction processing, cardholder enrolment, value loading, cardholder account management, reporting, and customer service.

3PEA International has expanded its PaySign® brand of prepaid cards to the automotive market with PaySign Connect for Automobile Dealerships. The complete PaySign Connect prepaid solution is a customizable, multi-purpose platform tailored to the distinctive needs of auto dealerships.

Also, 3PEA entered into an agreement with Visa, wherein 3PEA exclusively issues Visa-branded prepaid cards for the PaySign® brand.

Last month, 3PEA International announced that Mr. Dan Henry was elected Chairman of the Board. Since 2006, Mr. Mark Newcomer, Co-Founder of the Company, served as Chairman. Mr. Newcomer will assume the role of Vice Chairman and continue in his role as President and Chief Executive Officer (CEO).

Mr. Henry previously served as CEO of Netspend, now a TSYS company. He also served as President and Chief Operating Officer (COO) at Euronet Worldwide, which he co-founded.

Earlier this month, 3PEA International announced that it filed an application to list its common shares on the Nasdaq Capital Market.

3PEA International, Inc. (TPNL), closed Wednesday's trading session at $2.53, up 4.33%, on 80,690 volume with 89 trades. The average volume for the last 60 days is 55,983 and the stock's 52-week low/high is $0.3975/$2.67.


Kraken Robotics, Inc. (KRKNF)

4-Traders, Barchart, Stockhouse, OTC Markets, Morningstar, InvestorsHangout, and TradingView reported on Kraken Robotics, Inc. (KRKNF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Kraken Robotics, Inc.’s devotion is to the production and sale of software, sensors, and robotic systems for the global Unmanned Maritime Vehicles market. The Company’s wholly-owned subsidiary is Kraken Robotic Systems, Inc. On September 20, 2017, Kraken Sonar, Inc. announced that it changed its name from Kraken Sonar, Inc. to Kraken Robotics, Inc. Effective Friday, September 22, 2017; it began trading under its new name.

A marine technology company, Kraken Robotics is based in St. John’s, NL (Newfoundland and Labrador). The Company also has offices in Dartmouth, Nova Scotia; Bremen, Germany; and Fairfax, Virginia.

Kraken Robotics’ series of SAS (Synthetic Aperture Sonar) products called AquaPix® leverages close to 20 years of research and development (R&D) conducted by NATO’s Undersea Research Centre and millions of dollars in funding support from NATO government sponsors. AquaPix® provides comparable performance to existing high end military systems at a lesser cost.

AquaPix® can provide detailed seabed images with a constant resolution better than 3cm x 3cm out to a range of 300m from each side of an underwater vehicle (600m swath). In addition, it can produce 3D bathymetric data with a resolution better than 25cm x 25cm out to full range. This is while delivering very high depth accuracy, in compliance with IHO S44 special order requirements.

Kraken Robotics has expanded from sensors to complete systems. The Company has introduced its KATFISH™ tethered underwater vehicle. Moreover, it has introduced the THUNDERFISH® autonomous underwater vehicle (AUV).

In addition, the Company has its AQUATRAK® CVL product. This speed sensor is a derivative of its SAS technology. This product is for the oil and gas sector for ROVs.

Kraken Robotics also has its Kraken SeaVision™ system. This is an inventive new take on subsea 3D laser imaging. The design of it is to operate in a twin scanning configuration, with adjustable baseline. SeaVision can produce very high resolution 3D scans in full color.

Additionally, the Company has its DataPod™ product. The design of it is to meet modern data storage requirements for rugged marine applications. DataPod™ combines the user-friendliness of a Network Attached Storage system with the reliability of a RAID array and solid state storage all in one compact unit.

The Company’s Kraken Robotic Systems subsidiary has entered a strategic partnership with Avitas Systems, a GE Venture. The companies will integrate Autonomous Underwater Vehicles (AUVs), acoustic and laser sensor technology and artificial intelligence-based navigation software into innovative subsea inspection solutions for the oil and gas, offshore renewable energy, and shipping industries.

In January, Kraken Robotics announced that its German subsidiary, Kraken Robotik GmbH, was named a winner in the Carbon Trust's Offshore Wind Accelerator (OWA) competition. The OWA is a collaborative research and development (R&D) program funded by nine top offshore wind developers and the Scottish Government to lessen the cost of offshore wind energy. Kraken Robotik was one of only four companies selected in the competition.

At the end of January, Kraken Robotics announced that its wholly-owned subsidiary, Kraken Robotic Systems, Inc., was awarded a repeat contract valued at more than C$400,000 by a foremost military customer for its AquaPix® Miniature Synthetic Aperture Sonar system. Because of the confidential nature of the application, the customer's name is not disclosed. The expectation is that delivery will be in Q2 2018.

Kraken Robotics, Inc. (KRKNF), closed Wednesday's trading session at $0.14995, up 30.39%, on 226,610 volume with 43 trades. The average volume for the last 60 days is 57,448 and the stock's 52-week low/high is $0.10/$0.20.


PwrCor, Inc. (PWCO)

Amigo Bulls, Stockhouse, Barchart, InvestorsHub, MarketWatch, OTC Markets, and Stockopedia reported on PwrCor, Inc. (PWCO), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, PwrCor, Inc is a clean technology energy technology company. It is launching advanced and disruptive solutions for the Waste Heat to Energy, Geothermal, and Solar Thermal markets, and other applicable markets. In addition, PwrCor centers on energy infrastructure development projects and delivering cleantech energy solutions to commercial and not-for-profit customers. PwrCor is headquartered in New York, New York.

The Company also identifies, selects, and implements cost-effective and sustainable energy production technologies for its customers. It assists in different ways to finance those improvements. The PwrCor™ engines use proprietary technology, which can cost effectively convert ultra-low-grade heat to usable mechanical or electrical energy.

PwrCor™ utilizes no fossil fuels. It does not operate by way of combustion. It has no emissions, and does not process any working fluids that are flammable, harmful to the environment, or expensive to replace.

PwrCor™ is scalable and modular. Furthermore, it runs relatively silently, all within a small footprint.

PwrCor has commenced a program with Consolidated Edison, Inc. to develop a pilot project based on its proprietary PwrCor™ engine technology. The program is founded on PwrCor’s advanced green waste-heat-to-power technology in an application that captures waste steam condensate and converts it to electricity before it is disposed of in the municipal sewer system. The structure of the program is to culminate in a Pilot Project installation of a PwrCor engine at a suitable Con Ed customer site.

PwrCor’s proprietary technology can operate in the entire range of temperatures. Nonetheless, the Company expects to rapidly capture market share through expanding the market into lower temperature resources.

PwrCor can make a customer’s power generation more efficient. The Company can assist them in tapping renewable energy sources, therefore qualifying them as providing renewable energy.

Last month, PwrCor announced that the manufacture, initial testing, and trial runs of its first engine have been completed successfully. This engine is built to operate using ultra-low-grade heat from a geothermal source.

This marks a significant milestone to provide clean, “green” electrical power to the Surprise Valley Hot Springs Resort in Modoc County, California. The engine was designed and constructed at Southwest Research Institute in San Antonio, Texas. It is the first of its type that deploys PwrCor’s proprietary technology.

PwrCor, Inc. (PWCO), closed Wednesday's trading session at $0.18, up 42.57%, on 101,080 volume with 14 trades. The average volume for the last 60 days is 15,535 and the stock's 52-week low/high is $0.0865/$0.51.


Millennial Lithium Corp. (MLNLF)

Streetwise Reports, Small Cap Leader, Stockpulse, The Street, Penny Stock Tweets, Investing News, TradingView, OTC Markets, TipRanks, Insider Financial, Stockwatch, Junior Mining Network, Morningstar, Barchart, Stockhouse, 4-Traders, Metals News, Investors Hub, and Zacks reported on Millennial Lithium Corp. (WRTC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Millennial Lithium Corp. is an emerging exploration and development company headquartered in Vancouver, British Columbia. The Company is focusing on world class lithium assets in Argentina. Its commitment is to advancing the Pastos Grande Lithium project and the Cauchari East lithium project. Millennial Lithium’s shares trade on the OTC Markets Group’s OTCQX.

Millennial Lithium controls greater than 35,000 hectares of claims in the core of the Lithium Triangle. The Lithium Triangle is home to the world’s most prolific lithium deposits.

The Cauchari East Project is one of the world’s most prospective, shovel-ready lithium brine development projects. It is at the heart of the Lithium Triangle.

The ready availability of plenty of regional mining infrastructure offers the prospect of lowered Capex (capital expenditures) and operational expenditures at Cauchari East. Millennial Lithium is working towards the completion of a 43-101 resource calculation.

The Pastos Grandes Project is the Company’s flagship project. This Project is in Salta Province, Argentina. Currently, the Pastos Grandes Project covers 6,361 hectares. This makes Millennial Lithium the most active company in this expansive salar.

Millennial Lithium has an option to acquire 100 percent of the Pastos Grandes Lithium Project. The timeline to production is three years and 9 wells have been drilled and $9 Million spent in development.

On December 21, 2017, Millennial Lithium entered into the final agreement with the Salta Provincial Energy and Mining Company (REMSA) for the acquisition of 2,492 hectares of claims strategically located in the Pastos Grandes Salar and neighboring the Company’s current land holdings there. Completion of this acquisition brings Millennial Lithium’s holdings at Pastos Grandes to 8,664 hectares.

In February 2018, Millennial Lithium announced that it filed a Preliminary Economic Assessment (PEA Report) concerning its Pastos Grandes Project in the province of Salta, Argentina. The PEA Report, titled "Preliminary Economic Assessment of the Pastos Grandes Project Salta Province, Argentina" and dated February 23, 2018, was prepared by WorleyParsons.

Recently, Millennial Lithium reported that it received the environmental permit to begin exploration on the properties awarded to it by the Salta Provincial Energy and Mining Company (REMSA). The REMSA Properties form a part of Millennial Lithium’s Pastos Grandes project.

Millennial Lithium’s intention is to complete a Feasibility Study (FS) of the Pastos Grandes project, with the additional studies to support it. This includes a production well field model and reserves estimation.

This month, Millennial Lithium reported that it was granted the environmental permit to conduct geophysics and a drilling program of up to 6 wells on its Cauchari East lithium brine target in Jujuy Province, Argentina.

Farhad Abasov, Millennial Lithium’s President and Chief Executive Officer, stated, "We are pleased to have reached this milestone towards advancing exploration in this increasingly important lithium producing region. We are committed to exploring this target which adjoins known mineralization as defined by the two other explorers and developers in the Cauchari-Olaroz basin and which hosts the only new brine producer of the past 30 years, Orocobre's Salar de Olaroz Lithium Facility.”

Millennial Lithium Corp. (WRTC), closed Wednesday's trading session at $1.59, down 0.84%, on 43,506 volume with 52 trades. The average volume for the last 60 days is 40,896 and the stock's 52-week low/high is $0.9478/$3.8694.


Namaste Technologies, Inc. (NXTTF)

InvestorsHub, Stockhouse, OTC Markets, MarketWatch, InvestorsHangout, TradingView, and Daily Marijuana Observer reported on Namaste Technologies, Inc. (ANVV), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Namaste Technologies, Inc. is the largest online retailer for medical cannabis delivery systems worldwide. The Company distributes vaporizers and smoking accessories via e-commerce sites in 26 nations and with 5 distribution hubs located internationally. Namaste’s long term strategy is to become a leading supplier of legal cannabis products as the cannabis market is legalized in each nation.

Namaste Technologies has its corporate office in Toronto, Ontario. The Company’s U.S. office is in Jupiter, Florida. Its Bahamas office is in Lyford Cay. Namaste Technologies lists on the OTC Markets Group’s OTCQB.

The Company has majority market share in Europe and Australia. It has operations in the United Kingdom, the United States, Canada and Germany. Furthermore, Namaste has opened new supply channels into developing markets. This includes Brazil, Mexico, and Chile.

By way of vaporizer sales and the selling of glass and pipes and other dry herb related paraphilia, Namaste Technologies has a very strong channel to sell to end consumers once it is legalized around the world.

The Company owns and operates online retail sites with a presence in many nations. It is a global leader in delivery systems for dry herbs that can include medicinal cannabis where legally available.

Namaste Technologies has acquired Cannmart, Inc. This is a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program). Via Cannmart, Namaste is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian marketplace. In addition, Namaste Technologies is active in product development and manufacturing. Wholly-owned subsidiary Cannmart has received its Access to Cannabis for Medical Purposes Regulations (ACMPR) Production License.

Earlier this month, Namaste Technologies announced that it signed a supply and distribution agreement with Lowell Herb Co. (Lowell Smokes) to launch Lowell Smokes brand of ultra-premium cannabis products for the Canadian recreational and medical cannabis markets. This Agreement represents a strategic partnership between Namaste Technologies and Lowell Smokes to take advantage of Namaste's resources and Lowell Smokes’ worldwide brand appeal.

Last week, Namaste Technologies announced that further to the Company’s April 25, 2018 announcement of a Letter of Intent (LOI) with Pineapple Express Delivery, Inc., it signed a Subscription Agreement to acquire 15 percent of the share capital of Pineapple Express Delivery for $1,000,000. Namaste Technologies also announced that Pineapple Express Delivery secured a Courier Services Agreement with Ample Organics, Canada's foremost seed-to-sale software platform, for same-day cannabis delivery.

This week, Namaste Technologies announced that further to its January 18, 2018 LOI, it signed a subscription agreement to acquire 10 percent of the issued share capital of Israeli licensed producer of medical cannabis, Cannbit Ltd. for NIS 2,500,000 or roughly CAD $908,000 that includes a combination of cash and shares.

Namaste Technologies, Inc. (ANVV), closed Wednesday's trading session at $4.12, up 3.00%, on 443,294 volume with 354 trades. The average volume for the last 60 days is 415,894 and the stock's 52-week low/high is $0.1337/$3.4715.


MPX Bioceutical Corporation (MPXEF)

OTC Markets, OTC Dynamics, Jet Life Penny Stocks,, Barchart, Investing News Alerts, Penny Stock Hub, Stockhouse, MarketWatch, InvestorsHub, Stockwatch,, 4-Traders, TradingView, and High Rising Stocks reported on MPX Bioceutical Corporation (MPXEF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MPX Bioceutical Corporation, via its wholly-owned subsidiaries in the United States, provides considerable management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannabis enterprises in Arizona. These businesses operate under the Health for Life (dispensaries) and the award-winning Melting Point Extracts (high-margin concentrates wholesale) brands. MPX also has operations in the State of Massachusetts.

MPX Bioceutical has its corporate headquarters in Toronto, Ontario. The Company previously went by the name The Canadian Bioceutical Corporation. It changed its name to MPX Bioceutical Corporation in November of 2017. The Company lists on the OTC Markets Group’s OTCQB.

MPX Bioceutical is a multi-state diversified cannabis company. It has operations focused in the United States in the adult use and medical cannabis markets. The Company has completed its agreement to acquire GreenMart operations in Nevada. Furthermore, it signed non-binding Letters of Intent (LOI) to purchase dispensary and production licenses in Maryland. In addition, MPX has applied for a license in Canada.

Furthermore, regarding Pharma-grade products, MPX Bioceutical signed a definitive agreement to establish a joint venture (JV) with Panaxia. This JV is to develop proprietary, smokeless pharma-grade products using cannabis. MPX’s corporate mission is to become a foremost commercial producer of medical marijuana and pharma-grade products in North America.

Last month, MPX Bioceutical announced that it, via its indirect wholly-owned subsidiary, S8 Management, is entering into management agreements with each of Rosebud Organics, Inc., which is authorized to purchase, process and sell medical cannabis products in Maryland, and Budding Rose, Inc., which is authorized to operate a dispensary and sell medical cannabis products in Maryland. With the management agreements, S8 Management will provide all management services normally required by a production facility, in the case of Rosebud, and a dispensary facility, in the case of Budding Rose.

Further to managing the facilities, MPX Bioceutical, via its wholly-owned subsidiary, CGX Life Sciences, Inc., will at the same time acquire options to purchase 100 percent of the issued and outstanding common stock of Rosebud for aggregate consideration of US$3,018,181.82, and Budding Rose for aggregate consideration of US$2,481,818.18.

This month, MPX Bioceutical announced the Company’s inclusion in the newly created Horizons Emerging Marijuana Growers Index ETF. As Horizon’s second marijuana focused fund, the design of the Index is to provide exposure to the performance of a basket of mainly North American publicly-listed small capitalization companies engaged in the cultivation, production and/or distribution of marijuana.

MPX Bioceutical Corporation (MPXEF), closed Wednesday's trading session at $0.7099, up 1.41%, on 623,534 volume with 285 trades. The average volume for the last 60 days is 695,775 and the stock's 52-week low/high is $0.2257/$0.935.


SilverSun Technologies, Inc. (SSNT)

Stocktwits, Zacks, NetworkNewsWire, Simply Wall St, InvestorsHub, MarketWatch, The Street, Street Insider, Business Insider, OTC Markets, Marketwired, Proactive Investors, TipRanks, Marketbeat, 4-Traders, Market Chameleon, and InvestingNote reported on SilverSun Technologies, Inc. (SSNT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

SilverSun Technologies, Inc. is a business application, technology and consulting company based in East Hanover, New Jersey. It provides strategies and solutions to meet its clients' information, technology, business management, and network and cybersecurity needs. Established in 2002, SilverSun Technologies lists on the Nasdaq Capital Market. The Company’s principal operating subsidiary is SWK Technologies. SilverSun operates in the Technology/Application Software industry.

The Company engages in the acquisition and build-out of technology and software companies involved in providing transformative business management solutions and professional consulting services to small- and medium-sized businesses in the manufacturing, distribution and service industries.

SilverSun is a value-added reseller of scalable, adaptable business application software. The Company provides solutions for accounting and business management, financial reporting, Enterprise Resource Planning (ERP), Warehouse Management Systems, Customer Relationship Management (CRM), and Business Intelligence.

SilverSun also has its own development staff building software solutions for Electronic Data Interchange, time and billing and a range of ERP enhancements. The Company’s services and technologies deliver context-relevant insight and perspective into critical business operations. This enables the Company’s clients to manage, protect and monetize their enterprise assets - on premise or in the cloud.

SilverSun Technologies’ proprietary, feature-rich and user-friendly EDI software is MAPADOC™. This software allows businesses to substantially cut data entry time through eliminating duplicate entries; to lessen expensive errors with trading partners; and to reduce mapping time by greater than 75 percent.

SilverSun Technologies’ has a Growth-Through-Acquisition strategy. At the heart of this growth strategy is its acquisition of application resellers and software publishers of innovative and proprietary solutions in the extensive and expanding, but highly fragmented, business solutions market.

In May, SilverSun Technologies announced that its wholly-owned subsidiary, SWK Technologies acquired  Info Sys Management, Inc. (ISM).  The company is a foremost Portland, Oregon-based reseller of Sage Software and Acumatica  solutions.

ISM also provides hosting services for business applications to customers throughout the U.S.   The purchase price for ISM and its affiliate is $1.7 million and the deal was effective June 1, 2018. ISM has offices in Portland, San Diego, Phoenix and Washington, D.C.

Furthermore, in May, SilverSun Technologies announced the creation of a dual-shore Security-as-a-Service (SaaS) operation, in partnership with CyberHat.  The new security service offering will enable partners and customers to take advantage of SilverSun’s leading security operations teams to meet their cybersecurity needs, especially in compliance-driven and regulated industries. CyberHat is a leading Israeli Security Operations Center (SOC).

SilverSun Technologies, Inc. (SSNT), closed Wednesday's trading session at $3.98, down 0.50%. The average volume for the last 60 days is 755 and the stock's 52-week low/high is $1.20/$5.00.


CIB Marine Bancshares, Inc. (CIBH)

Stock Traders Chat, Amigo Bulls, Investor Hangout, CapitalCube, Stockhouse, InvestorsHub, OTC Markets, MarketWatch, 4-Traders, Morningstar, Marketwired, Investopedia, Zacks, TradingView, GuruFocus, Wallet Investor, Money Hub, Wallmine, Penny Stock Hub, YCharts, and Silicon Investor reported previously on CIB Marine Bancshares, Inc. (CIBH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CIB Marine Bancshares, Inc. operates as the bank holding company for CIBM Bank. The Bank provides banking and related services for small and middle-market business customers. OTCQB-listed, CIB Marine Bancshares is based in Waukesha, Wisconsin. The Bank also has offices in Central and Northeastern Illinois, Milwaukee, and Indianapolis markets.

Incorporated in 1985, CIB Marine Bancshares operates through Banking and Mortgage Banking segments. It accepts demand, savings, as well as time deposits.

CIBM Bank operates as Marine Bank in its Indiana and Wisconsin markets, Central Illinois Bank in its central Illinois market, and Avenue Bank in its Chicagoland market. Located in Naperville, Illinois, the Avenue Mortgage division of the Bank serves all CIBM Bank markets.

CIBM Bank provides traditional banking services. These include a broad array of loan products. These include commercial loans, commercial real estate loans, commercial and residential construction loans, one-to-four family residential real estate loans, consumer loans, and commercial and standby letters of credit.

In addition, services the Bank provides include acceptance of demand, savings and time deposits; commercial paper and repurchase agreements, and other banking services.

This past April, CIB Marine Bancshares announced its results of operations and financial condition for Q1 of 2018. Pre-tax Net Income for the quarter ending March 31, 2018, was $1.0 million versus $0.9 million for March 31, 2017.

Pre-tax Basic Net Income per Share was $0.05 and $0.03 on a diluted basis for the quarter ending March 31, 2018, versus $0.05 and $0.02, respectively, for the same period ending March 31, 2017.

Mr. J. Brian Chaffin, CIB Marine Bancshares’ President and Chief Executive Officer, said in April, “We were able to improve pre-tax earnings in the first quarter of 2018 compared to the same period last year on improved net interest income and higher mortgage revenues. Our asset quality, reflected through our non-performing assets and non-accrual loan ratios, continued to improve and achieved new cyclical lows.”

CIB Marine Bancshares, Inc. (CIBH), closed Wednesday's trading session at $1.75, up 6.06%, on 5,500 volume with 9 trades. The average volume for the last 60 days is 7,458 and the stock's 52-week low/high is $1.30/$1.99.


Leading Edge Materials Corp. (LEMIF)

InvestorsHub, MarketWatch, Stockhouse, Investing News, and Metals News reported on Leading Edge Materials Corp. (LEMIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Leading Edge Materials Corp. acquired all of the issued and outstanding shares of Tasman Metals Ltd. through a plan of arrangement in August 2016. The main assets of the Company are in Scandinavia. Its core investments are matched to high growth markets, linked to the worldwide shift to low-carbon energy generation and energy storage.

Leading Edge Materials is headquartered in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.

Leading Edge Materials’ focus is on graphite, lithium, cobalt, rare earth elements (REEs), and tungsten. Its assets and research emphasis are towards the raw materials for Li-ion batteries (graphite, lithium, high purity aluminium); materials for high thermal efficiency building products (graphite, silica, nepheline); and materials that improve the efficiency of energy generation (dysprosium, neodymium, hafnium).

The Company has 100 percent ownership of the Norra Kärr rare earth element (REE) project. It also has 100 percent ownership of the fully permitted Woxna graphite facility.

Norra Kärr is one of the world’s primary heavy REE resources. Norra Kärr is in southern Sweden, approximately 300 km SW of Stockholm. It has an unusual enrichment in the most critical REEs: dysprosium (Dy), terbium (Tb) and yttrium (Y).

A Pre-Feasibility Study (PFS) completed on Norra Kärr in 2015 identified an array of opportunities to improve project economics while reducing capital expenditure (Capex) and minimizing the environmental footprint of the project.

Woxna is a fully permitted site. It has an open pit mine, a graphite processing facility, and a tailings storage dam already built. The site is permitted to feed 100,000 ton of graphitic rock annually. This allows for the production of about 10,000 tons of graphite concentrate.

Recently, Leading Edge Materials reported the initiation of an exploration alliance centered on lithium ion battery materials in Romania. The exploration alliance has highlighted cobalt and lithium opportunities, for which secure tenure is presently being sought (the Exploration Area).

Leading Edge Materials signed a share purchase agreement with an arm's length party under which a local company was incorporated in Romania. With this Share Purchase Agreement, Leading Edge Materials will hold an initial 51 percent interest in the Partnership Company and the right to acquire up to 91 percent interest by making certain payments in shares of Leading Edge Materials, including an initial payment of 367,006 LEM Shares. Both parties are working to finalize the terms of a shareholders joint venture agreement.

Leading Edge Materials Corp. (LEMIF), closed Wednesday's trading session at $0.453, up 0.22%, on 28,460 volume with 24 trades. The average volume for the last 60 days is 61,884 and the stock's 52-week low/high is $0.41/$0.80.


SANUWAVE Health, Inc. (SNWV)

Greenbackers, OTCJournal, FeedBlitz, AllPennyStocks, OTC Stock Review, Explicit Penny Picks, Free Investment Report, Free Penny Alerts, Gladiator Stocks, InsidersLab, KillerPennyStocks,, RedChip, TopPennyStockMover, SmallCapVoice, PennyStocks24, OTC Stock Review, Penny Stock Rumble, Streetwise Reports, The Green Baron, and Ox of Wallstreet reported on SANUWAVE Health, Inc. (SNWV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets’ OTCQB, SANUWAVE Health, Inc. is a shock wave technology business. The Company’s initial concentration is on the development and commercialization of patented non-invasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue, as well as vascular structures. SANUWAVE Health researches, designs, and manufactures, markets and services its products around the world. SANUWAVE Health is based in Suwanee, Georgia.

The Company’s lead product candidate for the international wound care market, dermaPACE®, is CE marked across Europe. It has Canada, Australia, and New Zealand device license approval for the treatment of skin and subcutaneous soft tissue.

Last month, SANUWAVE Health announced that the U.S. Food and Drug Administration (FDA) issued its decision on the de novo submission for the dermaPACE® System.  Their decision (dated December 28, 2017) permits the marketing of the dermaPACE System as a Class II medical device used for the treatment of Diabetic Foot Ulcers (DFU) in the United States.

SANUWAVE applies its patented Pulsed Acoustic Cellular Expression (PACE®) technology in wound healing, orthopedic/spine, plastic/cosmetic, and cardiac conditions. The Company’s portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic responses. This produces new vascularization and microcirculatory improvement. This helps in restoring the body's normal healing processes and leads to regeneration of tissue.

The Company’s belief is that it has demonstrated that its technology is safe and effective in stimulating healing in chronic conditions of the foot (plantar fasciitis) and the elbow (lateral epicondylitis) through its U.S. Class III PMA approved OssaTron® device, and also stimulating bone and chronic tendonitis regeneration in the musculoskeletal environment via the use of its OssaTron, Evotron® and orthoPACE® devices in Europe, Asia, and Asia/Pacific.

In addition, there are license/partnership opportunities for SANUWAVE Health’s shock wave technology for non-medical uses. This includes energy, water, food, and industrial markets.

This month, SANUWAVE Health announced a partnership agreement was reached with Premier Shockwave Wound Care, Inc. and Premier Shockwave, Inc. (collectively Premier).  This agreement will cover the Veteran’s Administration (VA), Indian Health Service (IHS) and Tribally operated healthcare services, and US Military facilities/bases (MTFs).

With this agreement, Premier will purchase an undisclosed number of dermaPACE units to service these end markets. SANUWAVE Health will receive revenue from the sale of the equipment and a per procedure fee from Premier. This contract includes a minimum purchase of 100 units over three years.

The expectation is that the contract will provide a high margin, recurring revenue as Premier rolls out its services. The agreement allows SANUWAVE to enter the market immediately, thus speeding up revenue growth by years.

SANUWAVE Health, Inc. (SNWV), closed Wednesday's trading session at $0.3981, up 2.34%, on 78,082 volume with 22 trades. The average volume for the last 60 days is 165,780 and the stock's 52-week low/high is $0.09/$0.6419.


NeuroOne Medical Technologies Corporation (NMTC)

OTC Markets, Street Insider, Trading View, Wallmine, Marketbeat, Business Insider, InvestorsHub, The Stock Market Watch, YCharts, 4-Traders, Stockopedia, and Penny Stock Hub reported on NeuroOne Medical Technologies Corporation (NMTC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

NeuroOne Medical Technologies Corporation focuses on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is changing the landscape of surgical care for neurological disorders through the development of high-definition, minimally invasive diagnostics and treatments. NeuroOne Medical Technologies has its head office in Eden Prairie, Minnesota. The Company lists on the OTC Markets Group’s OTCQB.

NeuroOne Medical Technologies focuses on the development and commercialization of thin film electrode technology for cEEG and sEEG recording, brain stimulation and ablation solutions for patients suffering from Epilepsy, Parkinson’s Disease, Dystonia, Essential Tremors and other related brain related disorders.

The Company believes that technology in its pipeline can improve outcomes through reducing the risk of infection; lessening inflammation of the brain during recording; and increasing accuracy and specificity of recorded brain activity.

NeuroOne also believes that technology in its pipeline can improve outcomes through minimizing invasiveness of the procedure; and decreasing time-consuming, cumbersome, and expensive technical use and management within facilities. The Company’s emphasis is on the development and commercialization of Diagnostic Recording and Therapeutic Modalities.

Recently, NeuroOne Medical Technologies announced the appointment of Dr. Joseph Madsen to its Scientific Advisory Board. Dr. Madsen is a pediatric neurosurgeon, Director of Epilepsy Surgery at Children’s Hospital in Boston, Massachusetts and Associate Professor of Harvard Medical School.

Dr. Madsen joins Dr. Greg Worrell (Mayo Clinic), Dr. Jamie Van Gompel (Mayo Clinic), Dr. Jorge Gonzalez (Cleveland Clinic), Dr. Greg Esper (Emory University), and Justin Williams, Ph.D. (Wisconsin University Research Foundation) on the Company’s current Scientific Advisory Board.

The primary goals for NeuroOne Medical Technologies this year are to file patent application(s) based on the submitted 2017 provisional patents, and complete pre-clinical study for its diagnostic and diagnostic/ablation combination depth electrode.

Additionally, primary 2018 goals include submitting a 510(k) application for cortical electrode in the second half of this year, ramping up production and hiring initial sales force representatives for cortical electrode. Moreover, primary goals include continuing to strengthen its Physician Advisory Board where appropriate.

NeuroOne Medical Technologies Corporation (NMTC), closed Wednesday's trading session at $4.12, up 3.00%, on 629 volume with 9 trades. The average volume for the last 60 days is 3,247 and the stock's 52-week low/high is $2.50/$6.00.


The QualityStocks Company Corner

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF)

The QualityStocks Daily Newsletter would like to spotlight Marifil Mines Ltd. (MFMLF).

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF), headquartered in Vancouver, Canada, is engaged in the exploration, evaluation and acquisition of mineral rich resource properties in Argentina. A rising global demand for cobalt and lithium is generating interest in Marifil Mines and its resources located within South America’s famed “Lithium Triangle,” which include 15,267 hectares spanning its recently acquired Ratones and Fraile claims, as well as two lithium properties covering the southern portions of the Carachi Pampa salar in the Argentine province of Catamarca.

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF), headquartered in Vancouver, Canada, is engaged in the exploration, evaluation and acquisition of mineral rich resource properties in Argentina. A rising global demand for cobalt and lithium is generating interest in Marifil Mines and its resources located within South America’s famed “Lithium Triangle,” which include 15,267 hectares spanning its recently acquired Ratones and Fraile claims, as well as two lithium properties covering the southern portions of the Carachi Pampa salar in the Argentine province of Catamarca.

The company’s property also includes the Las Aguilas nickel-copper-cobalt deposit property, with more than four contiguous claims in the San Luis province of Argentina. The Las Aguilas property, which is 100% owned by Marifil, is noted as one of the largest cobalt properties in Argentina. Other noteworthy properties in the company’s portfolio include the Toruel copper-silver property, with more than two contiguous claims, and additional potash properties in Punta Colorada, Pedernal and El Carmen.

Marifil’s sizable portfolio of cobalt and lithium claims in what is recognized as the world’s most prolific mining jurisdiction for these resources strategically positions the company to benefit as global initiatives push demand for lithium-ion batteries toward a frenzy. Zion Market Research, a leading research and consulting firm, has forecast that the lithium-ion battery market could hit $67 billion by 2022, realizing a CAGR of more than 13.7% from 2017-2022. Both lithium and cobalt are major components of these energy storage solutions, with industry data indicating that the battery industry currently consumes roughly 42 percent of global cobalt production.

The company is reviving a lithium exploration program that was active in Argentina a decade ago, building on an unexplored mine it owns there. Marifil will utilize a large proprietary geologic and geochemical data base it developed during its 2009 lithium exploration program in the Salta and Catamarca province sites to resume lithium exploration in the region.

Applications for a second mine and negotiations to purchase a third property are underway, which would establish a significant property portfolio of ‘salar’ brine evaporation lakes. Hydrothermal solutions emanating from regional faults in area volcanoes often enrich the brine with lithium, boron, potassium and magnesium.

In addition to nearly 152,000 acres of lithium-staked properties, Marifil owns 887 acres of land for cobalt exploration and 91,565 acres of gold mining rights in an advanced exploration stage in San Roque that company engineers indicate has high gold discovery potential with “excellent infrastructure and mining friendly politics.”

To date, more than $7.5 million has been invested assessing Marifil’s flagship San Roque gold property, including nearly 16,000 meters of diamond core drilling. The property is jointly owned by Marifil and Novagold Resources, with Marifil holding a 51% stake and serving as the current project operator. The company recently commenced a drilling campaign to further evaluate several deposits of significant gold-silver-indium-lead-zinc mineralization on a 4-kilometer-long zone.

Marifil has closed a private placement funding for $2 million that will inject additional life into the company. Proceeds from the funding will benefit acquisition plans, the ongoing drilling program at Marifil’s gold claim and other output from its general working capital accounts.

Robert Abenante, a chartered professional account, serves as president and chief executive officer of the company. He has extensive experience in the public markets and has served as an officer and director of several public and private companies across various industries, with particular success in the mining sector.

Marifil Mines Ltd. (MFMLF), closed the day's trading session at $0.1352, off by 9.14%, on 5,000 volume with 1 trade. The average volume for the last 60 days is 1,700 and the stock's 52-week low/high is $0.01/$0.165.

Recent News


PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) was highlighted in a CannabisNewsWire report on the Cannabis Act being approved by the Canadian Senate in a vote of 52-29 after already passing the House of Commons.

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.0629, up 13.13%, on 72,200 volume with 9 trades. The average volume for the last 60 days is 19,948 and the stock's 52-week low/high is $0.002/$0.20.

Recent News


Sharing Services, Inc. (OTC: SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Sharing Services, Inc. (OTC: SHRV) today reports that gross sales for the month of April have reached a new milestone following the release of a new health and wellness product line.  April sales are to be reported at just over $3.5 million, representing an all-new record.

Sharing Services, Inc. (OTC: SHRV) headquartered in Plano, Texas, is a diversified holding company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth, and sending as many successful company “families” as possible on vacation.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders –  Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed the day's trading session at $0.36, up 9.09%, on 24,632 volume with 11 trades. The average volume for the last 60 days is 34,954 and the stock's 52-week low/high is $0.125/$1.07.

Recent News


Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF)

The QualityStocks Daily Newsletter would like to spotlight Hiku Brands Co. Ltd. (DJACF).

Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) was highlighted in a CannabisNewsWire report on the Cannabis Act being approved by the Canadian Senate in a vote of 52-29 after already passing the House of Commons.

Headquartered in British Columbia’s picturesque Okanagan Valley, Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) iis a premium cannabis lifestyle brand growing high-quality handcrafted cannabis flower. Hiku’s wholly owned subsidiary is a licensed producer of cannabis under the ACMPR that has requested its Pre-Sales License Inspection, the last step prior to receiving a license to sell cannabis under the ACMPR. Hiku’s Dominion Facility is a state-of-the-art ACMPR licensed production facility capable of producing approximately 660 kg year of dried cannabis flower. Hiku’s second facility, a 22,580 sq ft warehouse, “the FUTURE LAB”, is targeting its Phase 1 completion by Q2 2018 and once the facility is fully built-out utilizing an industry leading multi-tier system powered by LED lighting provided by Fluence BioEngineering, Hiku’s annual production capacity is expected to be in excess of 5,000 kgs. Hiku was founded by the proven entrepreneurial team that started SAXX Underwear®.

On December 21, 2017, Hiku and TS Brandco Holdings Inc. (“Tokyo Smoke”) announced that they have entered into a binding Letter of Intent (“LOI”) to merger the two companies and create a uniquely positioned cannabis company combining a best-in-class craft cannabis producer with an award-winning lifestyle brand and retail-focused cannabis company. It is anticipated that the combined company resulting from the merger will use the name “Hiku Brands Company Ltd.” (“Hiku”) to refer to the brand house containing premium cannabis brands DOJA, Tokyo Smoke, and Van der Pop.

Hiku recently closed on a $10 million strategic equity investment from Aphria Inc. (“Aphria”) (TSX:APH and US OTC: APHQF) to expand their product offering ahead of the recreational market.

Upon completion of the merger, Hiku will have a robust cash position of approximately $31 million, which it plans to invest in expanding its cannabis production capacity, growing its retail footprint, and adding select brands to its portfolio through highly strategic and complementary acquisitions.

About Tokyo Smoke
Founded in 2015 by Alan and Lorne Gertner, Tokyo Smoke is an award-winning cannabis lifestyle brand that brings sophistication and design to the fast-growing industry. With immersive experiences and design-first, non-dispensary retail spaces selling coffee, cannabis accessories and design products, the brand has six locations in Canada, with plans to expand nationwide. Recently named “Brand of the Year” at the Canadian Cannabis Awards, Tokyo Smoke has showcased excellence in brand storytelling, and has developed an international reputation as the go-to destination for engaging content offerings within the industry. With the acquisition of fellow designer cannabis brand Van der Pop, and by partnering with Aphria Inc. (TSX: APH and US OTC: APHQF) and WeedMD (TSXV: WMD), Tokyo Smoke continues to be the leading Canadian brand in the cannabis space.

About Hiku
Hiku is focused on handcrafted cannabis production, immersive retail experiences, and building a portfolio of iconic, engaging cannabis lifestyle brands. Hiku is differentiated as the only Canadian craft cannabis producer with a significant national retail footprint and a growing brand house including premium cannabis lifestyle brands DOJA, Tokyo Smoke, and Van der Pop.

Hiku’s wholly owned subsidiary, DOJA Cannabis Ltd., is a federally licensed producer pursuant to the ACMPR, owning two production facilities in the heart of British Columbia’s Okanagan Valley. The company operates a network of retail stores selling coffee, clothing and curated accessories, across British Columbia, Alberta and Ontario.

Hiku Brands Co. Ltd. (DJACF), closed the day's trading session at $0.98, up 3.68%, on 409,746 volume with 743 trades. The average volume for the last 60 days is 240,354 and the stock's 52-week low/high is $0.20/$3.7899.

Recent News


Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) was highlighted in a CannabisNewsWire report on the Cannabis Act being approved by the Canadian Senate in a vote of 52-29 after already passing the House of Commons.

Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $1.06, up 12.96%, on 2,847,989 volume with 1,490 trades. The average volume for the last 60 days is 440,310 and the stock's 52-week low/high is $0.18/$1.049.

Recent News


Medical Cannabis Payment Solutions (OTC: REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Medical Cannabis Payment Solutions (OTC: REFG) was highlighted in a CannabisNewsWire report on the Cannabis Act being approved by the Canadian Senate in a vote of 52-29 after already passing the House of Commons.

Medical Cannabis Payment Solutions (OTC: REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.041, up 3.80%, on 151,284 volume with 33 trades. The average volume for the last 60 days is 605,066 and the stock's 52-week low/high is $0.0161/$0.092.

Recent News


The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (TSX: TGOD).

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) was recently highlighted alongside other cannabis-focused businesses in a Cannabis Industry Report for the week of June 11th by JGR Capital, a New York-based equity research firm. To view the full report, visit: Also today, TGODF was highlighted in a CannabisNewsWire report on the Cannabis Act being approved by the Canadian Senate in a vote of 52-29 after already passing the House of Commons.

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (TSX: TGOD), closed the day's trading session at $5.2896, up 1.06%, on 216,566 volume. The stock's 52-week low/high is $2.784/$7.565.

Recent News



The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO).

In the months leading up to California's July 1 testing deadline, EVIO Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry in North America, has expanded its presence within the state and is prepared for the increasing demand for testing services. Also today, CannabisNewsWire released a report on the company detailing EVIO’s recent expansion to meet increased cannabis testing demand following California’s July 1 testing deadline. To view the full press release, visit: Additionally, EVIO was highlighted in a CannabisNewsWire report on the Cannabis Act being approved by the Canadian Senate in a vote of 52-29 after already passing the House of Commons.

EVIO, Inc. (OTCQB: EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation’s leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today’s fastest growing industry.

EVIO, Inc. (EVIO), closed the day's trading session at $1.11, up 1.83%, on 122,035 volume with 102 trades. The average volume for the last 60 days is 84,563 and the stock's 52-week low/high is $0.47/$2.70.

Recent News



The QualityStocks Daily Newsletter would like to spotlight GTX Corp. (GTXO).

GTX Corp (OTC:GTXO), a GPS technology-focused holding company and pioneer in tracking and recovery products and solutions, announces it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").

GTX Corp. (OTC: GTXO) designs, manufactures and commercializes various products and services in the GPS tracking and monitoring business.  Operating domestically and internationally, via two subsidiaries engaged in the internet of things (IoT) and wearable technology industry. Founded in 2002 and headquartered in Los Angeles, California, the company is a pioneer in Smart GPS, cellular and Bluetooth Low Energy (BLE) tracking technology, offering complete, end-to-end tracking solutions through a proprietary IoT enterprise monitoring platform – the IoT Machine to Machine platform – backed by state-of-the-art hardware, software and connectivity solutions, patents and software algorithms.

Operating under the motto “We Put the ‘Where’ in Wearable Tech,” GTX’s main goal is to keep its customers connected to who and what matters most, with each of its patented tracking technologies providing real-time location coordinates on a map via a personalized portal. The company prides itself on offering not only technologies, but also effective solutions that provide safety, security and peace of mind by helping customers locate their loved ones or lost valuable items.

With a portfolio that includes more than 80 patents filed and issued and with products and services available in 35 countries, GTX’s tracking solutions use the latest in miniaturized, low-power GPS, mobile, RF and BLE technology, that can integrate seamlessly with multiple consumer products, enterprise and military applications. The company became a U.S. Military contractor in 2017 and is already developing asset and human tracking technology for the U.S. Air Force. Its list of customers also includes public health authorities and municipalities, emergency and law enforcement, NGOs, private companies, public and private senior care homes, and consumers.

The company’s flagship product is the award-winning GPS SmartSole®, the world’s first invisible wearable tracking device created specifically for people at risk of wandering, becoming lost or disoriented, including patients with Alzheimer’s, autism, dementia, traumatic brain injury and other cognitive problems. According to the World Alzheimer Report 2013 (, there are more than 100 million people worldwide who need constant care and monitoring because of a cognitive disorder, and their number is expected to rise to 277 million by 2050. Due to its hidden location – inside a shoe insert, the device can also be used by people undercover or at risk of kidnapping, such as government agents, military personnel, law enforcement, journalists, corporate executives, etc.

Other tracking devices designed and commercialized by the company for civilian or military use include:

  • Take-Along Tracker 3G: A powerful mini-tracking device with GPS, 2G and 3G GSM data and voice capabilities, as well as a motion sensor and sleep mode. The device can be easily attached to a keychain, lanyard, dog collar, pocket, bag or plush toy for a discreet but advanced tracking solution.
  • Invisabelt: Designed for children, this slim GPS tracker hidden inside a small waistband belt has a battery life of up to two days and is a great solution for parents who want to monitor their children’s location at all times.
  • Track My Workforce: An easy and cost-effective solution that allows businesses to track and monitor their mobile workforce. The app is available for both Android and iOS systems, and allows employers to monitor their workforce from a single company account.
  • E.T.S. -Personnel Equipment Tracking System: Currently in use at the Edwards Air Force Base, this tracking system allows real-time monitoring and surveillance of personnel and assets and has a 200+ square mile coverage. Solar powering capabilities and extend battery life allow the tracker to be used in areas without existing power sources.
  • GPS Rifle Tracker: The company’s smallest GPS tracker, designed to withstand shocks and water submersion due to its robust, military standard enclosure, can be mounted on any AR15 platform picatinny rail to detect weapon discharge, track weapons and inventory, and send time and location alerts.

Led by a management team with solid experience in wearable technology, IoT, consumer electronics, mobile and technology licensing, as well as finance and the footwear industry, GTX plans to leverage its core technology platform to reach new verticals via licensing agreements and strategic partnerships, and to monetize its intellectual property portfolio. The monetization campaign kicked off in 2017 has already identified 100 companies that could become licensees. Besides military and law enforcement, the company also eyes the biometrics market, home health, medicare and insurance and other security applications for potential uses of its IoT platform and tracking technology.

GTX currently has 15 domestic and international distributors, subscribers in 35 countries and more than 700 online affiliates. With multiple revenue streams, several consecutive years of double-digit revenue growth and a strong pipeline of lucrative commercial products, GTX is uniquely positioned to become a leading provider of tracking solutions on this growing multi-billion-dollar market.

GTX Corp. (GTXO), closed the day's trading session at $0.0021, even for the day, on 4,069,646 volume with 30 trades. The average volume for the last 60 days is 4,236,504 and the stock's 52-week low/high is $0.0019/$0.0089.

Recent News


BLOCKStrain Technology Corp. (TSX-V: DNAX)

The QualityStocks Daily Newsletter would like to spotlight BLOCKStrain Technology Corp. (DNAX).

BLOCKStrain Technology Corp. (TSX-V: DNAX) will be celebrating its recent listing on the TSX-V by ringing the bell at the start of trading Thursday June 21,  on the Toronto Stock Exchange. Also today, the company was highlighted in a CannabisNewsWire report on the Cannabis Act being approved by the Canadian Senate in a vote of 52-29 after already passing the House of Commons.

BLOCKStrain Technology Corp. (TSX-V: DNAX), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:

  • Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
  • DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
  • Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.


BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.


BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.

It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry.  This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.


BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.

Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.

In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.

BLOCKStrain Technology Corp. (DNAX), closed the day's trading session at $0.375, even for the day. The stock's 52-week low/high is $0.10/$1.20.

Recent News


Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSXV:PQE; OTC:PQEFF; Frankfurt:A2DYWC) (“Petroteq” or the “Company”), a company focused on the development and implementation of proprietary technologies for the energy industry, is pleased to announce a new initiative to expand size and scope of its Advisory Board.

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $0.80278, up 0.35$, on 202,325 volume with 124 trades. The average volume for the last 60 days is 115,165 and the stock's 52-week low/high is $0.2395/$1.8892.

Recent News


Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) ("Lithium Chile" or the "Company") is pleased to announce that it has received written consent from the community of Ollague to begin an exploration drilling program on its Ollague project. With drill mobilization now underway, Lithium Chile expects drilling to begin shortly. 

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.7552, off by 4.41%, on 71,234 volume with 62 trades. The average volume for the last 60 days is 21,449 and the stock's 52-week low/high is $0.5946/$0.9614.

Recent News


Hammer Fiber Optic Holdings Corp. (OTCQB: HMMR)

The QualityStocks Daily Newsletter would like to spotlight Hammer Fiber Optic Holdings Corp. (HMMR).

Hammer Fiber Optic Holdings Corp. (OTCQB: HMMR) was highlighted today in an article examining how the company is pioneering a technology built on a hybrid architecture between fiber optic long haul infrastructure and high capacity wireless last mile innovation. This hybrid helps solve one of the greatest challenges in bringing fiber optic to the masses.

Hammer Fiber Optic Holdings Corp. (HMMR), with headquarters in New Jersey, is a telecommunications company investing in the future of wireless technology. The company’s holdings include Hammer Fiber Optic Investments, Ltd., D/B/A Hammer Fiber, an Internet Service Provider (ISP) that offers internet, voice, video and data services in New Jersey as well as carrier services in Philadelphia and New York. Hammer Fiber serves residential and small business markets with high-capacity broadband, voice and video through direct fiber as well as its wireless fiber platform – Hammer Wireless® AIR technology.

Hammer Fiber recently completed the initial development phase of its advanced LTE fixed wireless system, which was designed and built upon its successfully deployed wireless technology suite. The expansion allows Hammer Fiber to add ultra-high capacity cellular broadband applications to its product portfolio including wholesale services such as backhaul support for cellular network operators. Designed to complement Hammer Fiber’s core business of home residential service, the company expects this latest innovation to help position Hammer Fiber as a leader in future 5G technology. The company intends to leverage the Fixed LTE system in conjunction with its already deployed Fixed Wireless DOCSIS 3.1 system to deliver on one of its core promises, to deliver high capacity broadband to markets across the country at dramatically lower cost than traditional wireline methods, including fiber. Live field testing of the new system begins in early 2018 in the U.S. with service availability to follow later in the year.

Hammer Fiber has also expanded its IaaS (Infrastructure-as-a-Service) cloud services to include support for the cryptocurrency and blockchain industry. Interested companies will be able to host their products over Hammer Fiber’s robust and modern server infrastructure, fiber network architecture and data center presence in some of the most secure locations in the New York, New Jersey and Philadelphia regions. Hammer Fiber’s servers feature best-in-class computing power, designed to allow enterprise businesses to reap the benefits of utilizing a cloud-based system without the massive cost of establishing or maintaining a corporate data center.

“Distributed architecture infrastructure, such as those utilized by blockchain entities mining cryptocurrencies or other new vertical markets utilizing blockchain technology, are growing exponentially and we are poised to fulfill a critical but fundamental need of this explosive new industry,” said Mark Stogdill, CEO of Hammer Fiber. “The distributed ledger architectures that blockchains are built on require secure and robust data processing networks, highly scalable power generation and a reliable fiber optic backbone infrastructure linking up data centers worldwide for them to exist, and that is what we at Hammer Fiber do really well.”

Hammer Fiber seeks to achieve its vision by employing an extremely qualified group of business professionals with diverse backgrounds and successful track records from a variety of related industries. HMMR’s seasoned leadership team combines startup expertise with a consummate understanding of the regional competitive telecommunications landscape in sales, marketing, engineering, construction and business development.

Hammer Fiber Optic Holdings Corp. (HMMR), closed the day's trading session at $1.30, off by 7.14%, on 245,503 volume with 302 trades. The average volume for the last 60 days is 68,943 and the stock's 52-week low/high is $0.882/$48.00.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.